High materiality8/10
Truist Securities Starts Axsome Therapeutics (AXSM) at Buy
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Truist initiates AXSM with Buy; target $285; price $203.10.
- Truist initiates AXSM with Buy; target 285; price 203.10.
Key facts
- 01
Target: $285
- 02
Posted price: $203.1
- 03
Analyst firm: Truist Financial
- 04
Analyst: Srikripa Devarakonda
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.